PFIZER REPORTS THIRD-QUARTER 2021 RESULTS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/25/2026
- Nasdaq, S&P end lower as tech stocks fall
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
Pfizer (PFE) Stock Rallies on Beat-and-Raise, Analysts Divided on How Shares Will React
November 2, 2021 8:44 AM EDTShares of Pfizer (NYSE: PFE) are trading over 3% higher in pre-open Tuesday after the company reported better-than-expected Q3 results and raised its FY guidance.
Pfizer reported EPS of $1.37 to easily beat the analyst estimate of $1.08. Revenue for the quarter came in at $24.1 billion versus the consensus estimate of $22.68 billion.
Dr. Albert Bourla, Chairman and Chief Executive Officer, stated: More than 75% of the revenues we have recorded up through third-quarter 2021 for Comirnaty(1) have come from... More
Pfizer (PFE) Tops Q3 EPS by 29c, Raises FY Guidance
November 2, 2021 6:48 AM EDTPfizer (NYSE: PFE) reported Q3 EPS of $1.37, $0.29 better than the analyst estimate of $1.08. Revenue for the quarter came in at $24.1 billion versus the consensus estimate of $22.68 billion.
GUIDANCE:
Pfizer sees 2021 EPS of $4.13-$4.18 (previously $3.95 to $4.05). Pfizer sees 2021 revenue of $81-82 billion (previously... More
